Characterization of C21ORF100 as a Novel Prostate Differentiation Antigen

Bettoni, Fabiana; Inoue, Lilian T; Pires, Lilian C; Parmigiani, Raphael B; Camargo, Anamaria A.
Appl. cancer res ; 25(3): 116-121, July-Sept. 2005.
Artículo en Inglés | LILACS, Inca | ID: lil-442312

Documentos relacionados

  1. Genetic polymorphisms at 19q13.33 are associated with [-2]proPSA (p2PSA) levels and provide additional predictive value to prostate health index for prostate cancer.
  2. Antioxidative stress protein SRXN1 can be used as a radiotherapy prognostic marker for prostate cancer.
  3. Genetic testing in prostate cancer management: Considerations informing primary care.
  4. Higher-order SPOP assembly reveals a basis for cancer mutant dysregulation.
  5. GraphPath: a graph attention model for molecular stratification with interpretability based on the pathway-pathway interaction network.
  6. Plasma DNA Analysis in Prostate Cancer: Opportunities for Improving Clinical Management.
  7. How to improve the diagnosis of prostate cancer.
  8. [Mechanism of piRNA in bisphenol A-promoted invasion and migration of prostate cancer cells].
  9. Special Issue: "Novel Researches and Perspectives on Prostate Cancer".
  10. DNA hypomethylation silences anti-tumor immune genes in early prostate cancer and CTCs.